Nivolumab-induced seronegative encephalitis

Cabral, G; Ladeira, F; Gil, N

Cabral, G (corresponding author), Hosp Egos Moniz, Ctr Hosp Lisboa Ocident, Dept Neurol, Lisbon, Portugal.

JOURNAL OF NEUROIMMUNOLOGY, 2020; 347 ():

Abstract

Immune checkpoint inhibitors (ICIs) have emerged as a new therapeutic tool for numerous types of cancer. Neurological complications have been reported......

Full Text Link